A Study to Evaluate the Pharmacokinetics and Safety of ASP015K in Healthy Chinese Subjects
Clinical trial NCT04143477 · COMPLETED
Trial details
- NCT number
- NCT04143477
- Sponsor
- Astellas Pharma China, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-05
- Primary completion
- 2020-12-21
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.